On July 8, 2025, Quanterix Corp completed its merger with Akoya Biosciences, where shareholders of Akoya will receive 0.1461 shares of Quanterix stock and $0.38 in cash per share held. Additionally, two directors resigned and were replaced as part of the merger agreement.